Amag Pharmaceuticals Inc (AMAG) Return on Equity ROE from the third quarter 2020 to third quarter 2019 and annually, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amag Pharmaceuticals inc   (NASDAQ: AMAG)

Amag Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Amag Pharmaceuticals Inc in the third quarter 2020?
Amag Pharmaceuticals Inc recorded a cumulative net loss of $-181 million during 12 months ending in the third quarter 2020, resulting in a negative return on equity (ROE) of -69.49%.

Within the Major Pharmaceutical Preparations industry 213 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2020 from 0 to 3504.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Equity Change -46.05 % -50.56 % -57.83 % -62.52 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -181 -223 -344 -466 -289
Return On Equity (TTM) -69.49 % -71.08 % -91.41 % -100.16 % -49.63 %
AMAG's Total Ranking # 3504 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 256 244 259 280 475
Seq. Equity Change 4.88 % -5.83 % -7.36 % -41.04 % -3.89 %
Seq. Net Income Change 11994.38 % - - - -

Back to AMAG Management Effectiveness >> AMAG's 5 Years Annual ROE >> Compare AMAG ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 214
Sector # 490
Overall # 3504

Return On Equity Statistics
High Average Low
52.19 %
-15.16 %
-99.79 %
(Dec 31 2014)   (Dec 31 2019)





AMAG Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions 280 747 790 934 932
Y / Y Equity Change -62.52 % -5.52 % -15.43 % 0.23 % 102.69 %
Net Income in Millions -468 -66 -199 -2 33
Y / Y Net Income Change - - - - -75.87 %
Return On Equity -167.13 % -8.81 % -25.21 % -0.27 % 3.52 %

Back to AMAG Management Effectiveness >> AMAG's 5 Years Annual ROE >> Compare AMAG ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AMAG's' Return on Equity at Yahoo Finance
AMAG's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AMAG's Competitors
Subscribers only: Roe for Amag Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for AMAG's Customers




Companies with similar Return On Equity at Sep 30 2020, within Healthcare Sector ROE

Date modified: 2026-09-26T07:14:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.